Objective:To analyze the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease(CHD).Methods:This prospective cohort study investigated and collected the clinical information of patients with stable CHD and observed the syndrome type at the baseline and6-month at follow-up,as well as the cardiovascular events during the 6-month and 12-month follow-up.The patients were divided into the event group and the non-event group.The interaction and the impact of syndrome evolvement on cardiovascular events were examined through multifactor dimensionality reduction(MDR)analysis and the results were verified by Chi-square test.Results:Totally 1,333 of 1,503 stable CHD patients enrolled met the inclusion criteria of MDR analysis.Among them,959(71.9%)cases were males and 374(28.1%)cases were females.Thirty seven cases had cardiovascular events during 6 to 12 months after the study began.The results of the MDR analysis and verification using Chi-square test showed that the development of cardiovascular events was positively correlated with interaction between blood stasis and toxic syndrome at the baseline,blood stasis at the baseline and qi deficiency at the 6-month follow-up,toxic syndrome at the baseline and qi deficiency at the 6-month follow-up,toxic syndrome at the base line and blood stasis at the 6-month follow-up,qi deficiency and blood stasis at the 6-month follow-up(P<0.05for all).Conclusions:Blood stasis,toxic syndrome and qi deficiency are important factors of stable CHD.There are positive correlation between cardiovascular events and syndrome evolution from blood stasis to qi deficiency,from toxic syndrome to qi deficiency and from toxic syndrome to blood stasis,indicating the pathogenesis of toxin consuming qi,toxin leading to blood-stasis in stable CHD patients prone to recurrent cardiovascular events.
The development of novel and efficient antiplatelet agents that have few adverse effects and methods that improve antiplatelet resistance has long been the focus of international research on the prevention and treatment of cardiovascular and cerebrovascular diseases.Recent advances in platelet proteomics have provided a technology platform for high-quality research of platelet pathophysiology and the development of new antiplatelet drugs.The study of blood stasis syndrome(BSS)and activated blood circulation of traditional Chinese medicine(TCM)is one of the most active fields where the integration of TCM and western medicine in China has been successful.Activated blood circulation herbs(ABC herbs)of Chinese medicine are often used in the treatment of BSS.Most ABC herbs have antiplatelet and anti-atherosclerosis activity,but knowledge about their targets is lacking.Coronary heart disease(CHD),BSS,and platelet activation are closely related.By screening and identifying activated platelet proteins that are differentially expressed in BSS of CHD,platelet proteomics has helped researchers interpret the antiplatelet mechanism of action of ABC herbs and provided many potential biomarkers for BSS that could be used to evaluate the clinical curative effect of new antiplatelet drugs.In this article the progress of platelet proteomics and its advanced application for research of BSS and ABC herbs of Chinese medicine are reviewed.
